TheProfitWatch

ENLV - Enlivex Therapeutics Ltd. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.13 0.02 (1.77%) --- --- --- 0.0 (0.0%) 0.01 (0.88%) 0.0 (0.0%) 0.01 (0.89%)

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Category: /stock/categories/na
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
57.14
VWAP:
1.14
RVol:
1.256

Events

Period Kind Movement Occurred At

Related News